Olanzapine Tablet, Film Coated
Product Images NDC 70518-1501

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 70518-1501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Olanzapine 15mg 70518 1501 01)

Mm2 (Olanzapine 15mg 70518 1501 01)
This is a prescription medication called Olanzapine, manufactured by Dr. Reddy's located in Shreveport, LA. Each tablet contains 15 mg of the drug. It is repackaged by RemedyRepack Inc. It is important to keep this and all medication out of reach from children. The package insert should be consulted for directions of use. It should be stored at 20-25°C (B-77°F) with excursions permitted at 15-30°C (59-26°F) [See USP]. The lot and source NDC numbers are also provided.*
FDA Label Image

Mm1 (Remedy Label)

Mm1 (Remedy Label)
OLANZapine is a medication available in the form of 15 mg tablets packed in a bottle of 30 tablets. It's an Rx-only medication packaged by Dr. Reddy's in Shreveport, LA, and repackaged by RemedyRepack in Indiana, PA. The medication must be kept out of the reach of children and to be stored at a temperature between 20-25°C (88-77°F), with excursions permitted from 15-30°C (59-86°F). Further instructions can be found in the package insert. LOT number, NDC number, and expiry date are visible.*
FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.